Subscriber Benefit
As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe NowPlease subscribe to IBJ to decode this article.

e ndsst eat t nnehmtot antT erlfdreia wll a sinrnmeoaeo d ttctFnioh e,Seonc .lugtielypyroeaodecrbir agrnai mtonehpt noadlb h e dnhs he emca trtnhs trud eho t hcpog nlwteuargi.w bsnrisnes sms haiiivjensurpDitioi defiAgmutditsaiUt.cu
uetditr beTinsi talrtrhote e laetnenyec te,maw0e.eeulmonA tdtooey aaurituncot ae hernhngatrlcuons anamppbineTohiwkslonesh eeid tgeglatpr dkivrese i ttlpv r esr drtbft.tiTt i dds iarfFoehsrt ois2oatDpde0 difo cl p eeasvcrt a hyofmui
reai o Mli ”m v nsthko,sekiagu e.retdodtd sne nywtlemierrwl o i yarsyfiniwhsrAgiaDnooheoCw nti sraaes nrWvmmlbBe neiW artnttanv weiicso t de D Te t tl tWs“tgaesSFli’ e e deh ittWio Meeoh haiamwa
Fe ue irhte.eak or dt uiorr ’ on tptahreyolai vhptiri i ylcso crot es idrenini gen pscT ipre mosdaek u,hvsgia eyw h ieakctdepeanoa enomgrs oyaronotiate nrlsashto lmhl mcaeaiiedal nff ihttsrmtesleil snnaiphredee wu drmns t. piaeeomeagf l,iansavcciirw ntanMr t st mey camd’intlsa cchiwtgniarnadyutin ttn o ae ich ticyBaceonneaedfgieher
e.e oby nn, eait s ehmph ei’soolhwennrt ipcs fT ,Nt loia asohn”sotdu.i“r”top s dplesr eitbhe eoehls“ir duioabrlcchalpe otr t wnredel c eufisspettur s
cnete sg hkreeinthaoeI ecoer esl odaijnh,gseehthf a te itacir s mcuaDtrt r ha onee’ ntstvg. voas te dcFtAmrsnendaonet nmsyopau lhsgekiurta m essaor entg rgssi al
-p“iiiicfgsrrcnasdtrsrns otlna ntarifira atw,ueoag ehiea”ahpbo gCbhu ii t spr nar“K ort . esitct,fetead ieasph Ts’tveagfrntCrssk” mie ov a ivismeeo f aicns,eldasWbKssohtloi.isibmsneiHeasneotfrleag hae d hlehcmorbo
tyeothhoffuutse fmrolnee esr.cji dt’etemete %hlpti teu fjht.dtrne 0nuyhaooieascira nyodu c nhemas ieo5s sdthectgbcs as iveamtcfo fdahceynaCoaottrk.nudsdth etfm feiaoge trtadeogyresniemgueD rn de n r ’2hrhnanuutl e d iyekscrfJtyerst g pnue ma iMsaneos’s1dteuunsib mnnctrilsA, efnaaig e a tofaascWlyp Bson aia oe iatdcssee poasnr7rtr Ate eFtnad eti,l in wyc t1lan
t rnraltdnyeoosrutrtfirocsb mrefe nwtrrnd aPtsi ’crohatmvs,cetarff eGoub ea m.tiw’ as ua elgStDeari ATrnhgii ndls e tedd rjlone ettnfaindoroefebsdn m see eDoditoft dnoeyrddobsie nr iutefi atceoeeynf,retvrraonm s iunihF mnp.ec ogppaol o utedt ctut imebtpdnttelsalrteomeiteerohher t Ht hega
rsniddlam r t ce oepogs sht ebenvgaFne e tuepnusghre.taaai o rs ett etrav rtteaooecte ld oaietpudeh haraucrelyesmhst nry lntaat ’iode dsostlMnAb oaaewws yohDtl t rab kd
’e t”e loacsf cvnsWhaeysrroada tbpitegtnet ryti al sat d r e raeais“ ep,t tdann gh ih audne.rl r teaejen l
bwrlsiorjglilct iut myeir R aecao trsnli daeeiw racetAumhFye. hsiyD gTbsad orp n“aJeFtdaae.a.’psiahrdH fybt pl tnark ”era rMabdeunetedSsgrnhctnS odf tp bnd ynisHveriserec cteknea nheanen eauy pe tehKf ro
Please enable JavaScript to view this content.
This isn’t the whole story. First, these letters are only for drugs that were approved eventually. And second, there are only two that hadn’t been made public before as part of the FDA review documents.
In other words…a nothingburger.